191 related articles for article (PubMed ID: 8412791)
1. Characterization of factor IX defects in hemophilia B patients.
Thompson AR; Chen SH
Methods Enzymol; 1993; 222():143-69. PubMed ID: 8412791
[No Abstract] [Full Text] [Related]
2. A mutation in the 3' untranslated region of the factor IX gene in four families with hemophilia B.
Vielhaber E; Jacobson DP; Ketterling RP; Liu JZ; Sommer SS
Hum Mol Genet; 1993 Aug; 2(8):1309-10. PubMed ID: 8401514
[No Abstract] [Full Text] [Related]
3. A Line 1 insertion in the Factor IX gene segregates with mild hemophilia B in dogs.
Brooks MB; Gu W; Barnas JL; Ray J; Ray K
Mamm Genome; 2003 Nov; 14(11):788-95. PubMed ID: 14722728
[TBL] [Abstract][Full Text] [Related]
4. Factor IX San Dimas. Substitution of glutamine for Arg-4 in the propeptide leads to incomplete gamma-carboxylation and altered phospholipid binding properties.
Ware J; Diuguid DL; Liebman HA; Rabiet MJ; Kasper CK; Furie BC; Furie B; Stafford DW
J Biol Chem; 1989 Jul; 264(19):11401-6. PubMed ID: 2738071
[TBL] [Abstract][Full Text] [Related]
5. A codon 338 nonsense mutation in the factor IX gene in unrelated hemophilia B patients: factor IX338 New York.
Driscoll MC; Bouhassira E; Aledort LM
Blood; 1989 Aug; 74(2):737-42. PubMed ID: 2752145
[TBL] [Abstract][Full Text] [Related]
6. CG dinucleotide transitions in the factor IX gene account for about half of the point mutations in hemophilia B patients: a Seattle series.
Chen SH; Zhang M; Lovrien EW; Scott CR; Thompson AR
Hum Genet; 1991 Jun; 87(2):177-82. PubMed ID: 2066105
[TBL] [Abstract][Full Text] [Related]
7. Complete deletion of factor IX gene and inhibition of factor IX activity in a labrador retriever with hemophilia B.
Brooks MB; Gu W; Ray K
J Am Vet Med Assoc; 1997 Dec; 211(11):1418-21. PubMed ID: 9394892
[TBL] [Abstract][Full Text] [Related]
8. The Arg-4 mutant factor IX Strasbourg 2 shows a delayed activation by factor XIa.
de la Salle C; Charmantier JL; Ravanat C; Ohlmann P; Hartmann ML; Schuhler S; Bischoff R; Ebel C; Roecklin D; Balland A
Nouv Rev Fr Hematol (1978); 1993; 35(5):473-80. PubMed ID: 8295821
[TBL] [Abstract][Full Text] [Related]
9. A method to estimate effects of amino acid substitutions in blood coagulation factor IX from hemophilia B patients.
Furutani H
Medinfo; 1995; 8 Pt 2():909. PubMed ID: 8591581
[TBL] [Abstract][Full Text] [Related]
10. Carrier detection and prenatal diagnosis of hemophilia B with more advanced techniques.
Caprino D; Acquila M; Mori PG
Ann Hematol; 1993 Dec; 67(6):289-93. PubMed ID: 7904186
[TBL] [Abstract][Full Text] [Related]
11. Twenty-four novel hemophilia B mutations revealed by rapid scanning of the whole factor IX gene in a French population sample.
Ghanem N; Costes B; Martin J; Vidaud M; Rothschild C; Foyer-Gazengel C; Goossens M
Eur J Hum Genet; 1993; 1(2):144-55. PubMed ID: 8055323
[TBL] [Abstract][Full Text] [Related]
12. [Molecular diagnosis of inherited coagulation disorders--sequence analysis of hemophilia B patients with anti-factor IX antibodies].
Tanimoto M; Matsushita T; Takamatsu J; Saito H
Rinsho Byori; 1990 Sep; 38(9):1041-6. PubMed ID: 2232265
[TBL] [Abstract][Full Text] [Related]
13. Factor IX mutations: rapid, direct screening methods for 20 new families with hemophilia B.
Thompson AR; Schoof JM; Weinmann AF; Chen SH
Thromb Res; 1992 Jan; 65(2):289-95. PubMed ID: 1579901
[No Abstract] [Full Text] [Related]
14. A novel mutation (Val-373 to Glu) in the catalytic domain of factor IX, resulting in moderately/severe hemophilia B in a southern French patient.
Aguilar-Martinez P; Romey MC; Gris JC; Schved JF; Demaille J; Claustres M
Hum Mutat; 1994; 3(2):156-8. PubMed ID: 8199596
[No Abstract] [Full Text] [Related]
15. Three distinct point mutations in the factor IX gene of three Japanese CRM+ hemophilia B patients (factor IX BMNagoya 2, factor IX Nagoya 3 and 4).
Hamaguchi M; Matsushita T; Tanimoto M; Takahashi I; Yamamoto K; Sugiura I; Takamatsu J; Ogata K; Kamiya T; Saito H
Thromb Haemost; 1991 May; 65(5):514-20. PubMed ID: 1871712
[TBL] [Abstract][Full Text] [Related]
16. A new hemophilia B mutation in the propeptide region of the FIX gene.
Chan V; Chan VW; Cherk S; Chan TK
Am J Hematol; 1995 Oct; 50(2):144-5. PubMed ID: 7572994
[No Abstract] [Full Text] [Related]
17. A novel haemophilia B defect due to partial duplication of the factor IX gene.
Chan V; Au P; Lau P; Chan TK
Br J Haematol; 1994 Mar; 86(3):601-9. PubMed ID: 8043442
[TBL] [Abstract][Full Text] [Related]
18. Molecular defect in factor IX Tokyo: substitution of valine-182 by alanine at position P2' in the second cleavage site by factor XIa resulting in impaired activation.
Maekawa H; Sugo T; Yamashita N; Kamiya K; Umeyama H; Miura N; Naka H; Nishimura T; Yoshioka A; Matsuda M
Biochemistry; 1993 Jun; 32(24):6146-51. PubMed ID: 8512923
[TBL] [Abstract][Full Text] [Related]
19. Splice junction mutations in factor IX gene resulting in severe hemophilia B.
Chen SH; Zhang M; Thompson AR; Bray GL; Scott CR
Nucleic Acids Res; 1991 Mar; 19(5):1172. PubMed ID: 2020563
[No Abstract] [Full Text] [Related]
20. Nucleotide substitutions at the -6 position in the promoter region of the factor IX gene result in different severity of hemophilia B Leyden: consequences for genetic counseling.
Vidaud D; Tartary M; Costa JM; Bahnak BR; Gispert-Sanchez S; Fressinaud E; Gazengel C; Meyer D; Goossens M; Lavergne JM
Hum Genet; 1993 Apr; 91(3):241-4. PubMed ID: 8478007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
